# NMTC (NeuroOne Medical Technologies Corporation) - SEC EDGAR Financial Statements

> NeuroOne Medical Technologies Corporation reported $10.00M in revenue and a net loss of $7.45M for the trailing twelve months ended June 30, 2026 (up 16.3% year over year), with a 55.7% gross margin and a -76.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/NMTC
- Markdown: https://convexityos.com/fundamentals/NMTC.md
- SEC CIK: 0001500198
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001500198&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $10.00M | +16.3% YoY |
| Operating Income | TTM | -$7.60M | -76.1% margin |
| Net Income | TTM | -$7.45M | -74.5% net margin |
| Diluted EPS | TTM | -$0.85 | Split-adjusted |
| Free Cash Flow | TTM | -$7.16M | -71.6% FCF margin |
| Cash & ST Investments | Jun 30, 2026 | $2.05M | Total debt: $175K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2016 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.10M | $3.45M | $1.95M | $171K | $178K | -- | -- | $0 | $0 | $773 |
| Cost of Revenue | $3.96M | $2.37M | $1.50M | $242K | $276K | -- | -- | -- | -- | -- |
| **Gross Profit** | $5.14M | $1.08M | $457K | -$71K | -$98K | -- | -- | -- | -- | -- |
| Research & Development | $4.98M | $5.07M | $6.94M | $4.93M | $3.93M | $2.08M | $1.53M | -- | -- | -- |
| Selling, General & Admin | $7.38M | $7.90M | $6.93M | $6.98M | $6.26M | -- | -- | -- | -- | -- |
| Total Operating Expenses | $12.37M | $12.97M | $13.87M | $11.91M | $10.19M | $6.83M | $5.81M | $33K | $31K | $37K |
| **Operating Income** | -$4.23M | -$11.89M | -$11.96M | -$10.03M | -$10.22M | -$4.90M | -$5.81M | -$33K | -$31K | -$36K |
| **EBITDA** | -$3.96M | -$11.64M | -$11.76M | -$9.91M | -$10.14M | -$4.85M | -$5.79M | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | $3.1K | -- | -- | -- | $14K | $330 |
| Income Before Tax | -$3.61M | -$12.32M | -$11.86M | -$10.00M | -- | -$2.02M | -- | -$33K | -$31K | -$36K |
| Income Tax Expense | -- | -- | -- | -- | -$271K | -- | -- | $0 | $0 | $0 |
| **Net Income** | -$3.61M | -$12.32M | -$11.86M | -$10.00M | -$9.95M | -$13.64M | -$6.78M | -$48K | -$63K | -$36K |
| Basic EPS | -$0.54 | -$2.76 | -$3.90 | -$3.78 | -$5.58 | -$15.12 | -$3.42 | -$0.06 | -$0.06 | -$0.06 |
| **Diluted EPS** | -$0.54 | -$2.76 | -$3.90 | -$3.78 | -$5.58 | -$15.12 | -$3.42 | -$0.06 | -$0.06 | -$0.06 |
| Basic Shares Outstanding | 6.7M | 4.5M | 3.0M | 2.7M | 1.8M | 902.8K | 2.0M | 845.7K | 845.7K | 845.7K |
| Diluted Shares Outstanding | 6.7M | 4.5M | 3.0M | 2.7M | 1.8M | 902.8K | 2.0M | 845.7K | 845.7K | 845.7K |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.97M | $2.39M | $2.89M | $2.74M | $1.70M | $1.39M | $3.27M | $272K |
| Cost of Revenue | $790K | $1.10M | $1.32M | $1.21M | $781K | $615K | $1.35M | $131K |
| **Gross Profit** | $1.18M | $1.29M | $1.57M | $1.53M | $915K | $771K | $1.93M | $141K |
| Research & Development | $1.43M | $1.47M | $1.39M | $1.12M | $1.18M | $1.51M | $1.17M | $1.11M |
| Selling, General & Admin | $2.18M | $1.92M | $1.89M | $1.78M | $1.62M | $1.94M | $2.04M | $1.84M |
| Total Operating Expenses | $3.61M | $3.39M | $3.28M | $2.90M | $2.80M | $3.45M | $3.22M | $2.96M |
| **Operating Income** | -$2.42M | -$2.10M | -$1.71M | -$1.37M | -$1.89M | -$2.68M | $1.71M | -$2.82M |
| **EBITDA** | -$2.38M | -$2.04M | -$1.64M | -$1.31M | -$1.82M | -$2.61M | $1.78M | -$2.75M |
| Income Before Tax | -$2.01M | -$2.09M | -$1.44M | -$1.62M | -$1.50M | -$2.27M | $1.79M | -$3.35M |
| **Net Income** | -$2.01M | -$2.38M | -$1.44M | -$1.62M | -$1.50M | -$2.27M | $1.79M | -$3.35M |
| Basic EPS | -$0.23 | -$0.25 | -$0.18 | -- | -$0.19 | -$0.44 | $0.36 | -- |
| **Diluted EPS** | -$0.28 | -$0.25 | -$0.18 | -- | -$0.19 | -$0.44 | $0.36 | -- |
| Basic Shares Outstanding | 8.7M | 8.5M | 8.4M | -- | 8.1M | 5.2M | 5.1M | -- |
| Diluted Shares Outstanding | 8.7M | 8.5M | 8.4M | -- | 8.1M | 5.2M | 5.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.57M | $1.46M | $5.32M | $8.16M | $6.90M | $4.04M | $261K | $13K | $26K | $522K |
| Short-Term Investments | -- | -- | -- | $2.98M | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $6.57M | $1.46M | $5.32M | $11.14M | $6.90M | $4.04M | $261K | $13K | $26K | $522K |
| Accounts Receivable, Net | $1.26M | $177K | -- | $33K | $48K | -- | -- | -- | -- | -- |
| Inventory | $2.23M | $2.64M | $1.73M | $705K | $98K | -- | -- | -- | -- | -- |
| **Total Current Assets** | $10.23M | $4.63M | $7.31M | $12.18M | $7.29M | $4.16M | $302K | $19K | $34K | $576K |
| Property, Plant & Equipment, Net | $259K | $417K | $526K | $354K | $223K | $166K | $52K | -- | -- | -- |
| Intangible Assets | $45K | $67K | $90K | $112K | $134K | $157K | $179K | $200K | $216K | $181K |
| **Total Non-Current Assets** | $559K | $739K | $784K | $647K | $646K | $605K | $231K | $200K | $216K | $181K |
| **Total Assets** | $10.79M | $5.37M | $8.10M | $12.82M | $7.94M | $4.76M | $533K | $219K | $250K | $757K |
| Accounts Payable | $1.01M | $1.03M | $685K | $928K | $529K | $763K | $1.15M | $221K | -- | $22K |
| Short-Term Debt | -- | -- | $129K | -- | -- | $1.01M | -- | -- | $253K | $50K |
| Deferred Revenue (Current) | -- | -- | -- | $1.46M | $8.6K | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $2.30M | $2.21M | $1.79M | $3.10M | $1.18M | $2.36M | $1.77M | $3.80M | $3.91M | $677K |
| Long-Term Debt | -- | -- | $55K | $120K | $203K | $254K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $1.41M | $2.33M | $55K | $120K | $203K | $338K | $0 | $817K | $1.38M | $346K |
| **Total Liabilities** | $3.71M | $4.55M | $1.85M | $3.22M | $1.38M | $2.69M | $1.77M | $4.61M | $5.29M | $1.02M |
| **Total Debt (incl. Leases)** | $267K | $260K | $369K | $239K | $406K | $1.52M | -- | -- | $253K | $50K |
| Common Stock | $8.3K | $31K | $24K | $16K | $12K | $22K | $13K | $9.7K | $7.9K | $31 |
| Retained Earnings | -$78.61M | -$75.00M | -$62.69M | -$50.83M | -$40.83M | -$30.88M | -$17.24M | -$10.46M | -$5.32M | -$266K |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | -- | -$50K | -- |
| **Total Stockholders' Equity** | $7.07M | $822K | $6.25M | $9.60M | $6.55M | $2.07M | -$1.24M | -$4.40M | -$5.04M | -$266K |
| Total Equity | $7.07M | $822K | $6.25M | $9.60M | $6.55M | $2.07M | -$1.24M | -$4.40M | -$5.04M | -$266K |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.05M | $2.80M | $3.56M | $6.57M | $8.04M | $1.32M | $1.13M | $1.46M |
| **Cash & Short-Term Investments** | $2.05M | $2.80M | $3.56M | $6.57M | $8.04M | $1.32M | $1.13M | $1.46M |
| Accounts Receivable, Net | $1.10M | $2.43M | $2.66M | $1.26M | -- | $319K | $2.37M | $177K |
| Inventory | $2.29M | $1.87M | $1.67M | $2.23M | $1.90M | $1.83M | $1.93M | $2.64M |
| **Total Current Assets** | $5.79M | $7.40M | $8.07M | $10.23M | $10.17M | $3.75M | $5.71M | $4.63M |
| Property, Plant & Equipment, Net | $202K | $231K | $245K | $259K | $315K | $335K | $382K | $417K |
| Intangible Assets | $28K | $34K | $39K | $45K | $51K | $56K | $62K | $67K |
| **Total Non-Current Assets** | $397K | $461K | $511K | $559K | $649K | $703K | $783K | $739K |
| **Total Assets** | $6.19M | $7.86M | $8.58M | $10.79M | $10.82M | $4.46M | $6.49M | $5.37M |
| Accounts Payable | $906K | $934K | $552K | $1.01M | $468K | $911K | $745K | $1.03M |
| **Total Current Liabilities** | $2.04M | $1.69M | $1.26M | $2.30M | $1.43M | $1.76M | $1.57M | $2.21M |
| **Total Non-Current Liabilities** | $377K | $802K | $917K | $1.41M | $1.22M | $1.57M | $1.99M | $2.33M |
| **Total Liabilities** | $2.42M | $2.49M | $2.18M | $3.71M | $2.64M | $3.33M | $3.56M | $4.55M |
| **Total Debt (incl. Leases)** | $175K | $207K | $237K | $267K | $296K | $311K | $342K | $260K |
| Common Stock | $8.7K | $8.6K | $50K | $8.3K | $50K | $31K | $31K | $31K |
| Retained Earnings | -$84.44M | -$82.13M | -$80.05M | -$78.61M | -$76.99M | -$75.49M | -$73.22M | -$75.00M |
| **Total Stockholders' Equity** | $3.77M | $5.08M | $6.40M | $7.07M | $8.18M | $1.13M | $2.94M | $822K |
| Total Equity | $3.77M | $5.08M | $6.40M | $7.07M | $8.18M | $1.13M | $2.94M | $822K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2016 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.61M | -$12.32M | -$11.86M | -$10.00M | -$9.95M | -$13.64M | -$6.78M | -$48K | -$63K | -$36K |
| Depreciation & Amortization | $262K | $247K | $199K | $119K | $81K | $48K | $28K | -- | -- | -- |
| Stock-Based Compensation | $1.26M | $1.34M | $1.11M | $947K | $1.79M | $1.84M | $324K | -- | -- | -- |
| Change in Receivables | -$1.09M | -$177K | $33K | $15K | -$48K | -- | -- | -- | -- | -- |
| Change in Inventory | $398K | -$908K | -$1.02M | -$606K | -$98K | -- | -- | -- | -- | -- |
| Change in Payables | $240K | $67K | -$247K | $515K | -$350K | -$270K | $771K | $12K | -$2.1K | -- |
| **Operating Cash Flow** | -$2.84M | -$11.01M | -$12.89M | -$7.52M | -$8.60M | -$3.43M | -$5.40M | -$21K | -$30K | -$26K |
| Capital Expenditure | -$82K | -$120K | -$384K | -$275K | -$67K | -$122K | -$58K | -- | -- | -- |
| **Free Cash Flow** | -$2.92M | -$11.13M | -$13.27M | -$7.79M | -$8.67M | -$3.55M | -$5.45M | -- | -- | -- |
| **Investing Cash Flow** | -$82K | -$120K | $2.65M | -$3.24M | -$67K | -$122K | -$123K | $0 | $0 | $0 |
| Common Stock Issued | -- | $837K | $2.55M | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $8.03M | $7.27M | $7.40M | $12.02M | $11.53M | $7.32M | $5.77M | $21K | $30K | $26K |
| **Net Change in Cash** | $5.11M | -$3.86M | -$2.84M | $1.26M | $2.86M | $3.78M | $247K | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.01M | -$2.38M | -$1.44M | -$1.62M | -$1.50M | -$2.27M | $1.79M | -$3.35M |
| Depreciation & Amortization | $47K | $60K | $66K | $64K | $67K | $66K | $65K | $64K |
| Stock-Based Compensation | $353K | $342K | $359K | $359K | $317K | $250K | $339K | $340K |
| Change in Receivables | $1.33M | $235K | -$1.40M | -$1.26M | $319K | $2.05M | -$2.19M | $234K |
| Change in Inventory | -$425K | -$200K | $561K | -$332K | -$71K | $96K | $704K | -$842K |
| Change in Payables | -$33K | $380K | -$440K | $527K | -$368K | $96K | -$15K | $22K |
| **Operating Cash Flow** | -$1.08M | -$1.33M | -$3.12M | -$1.53M | -$1.46M | -$56K | $208K | -$2.67M |
| Capital Expenditure | -$20K | -$39K | -$41K | -$11K | -$44K | -$3.2K | -$24K | -$37K |
| **Free Cash Flow** | -$1.10M | -$1.37M | -$3.16M | -$1.54M | -$1.51M | -$59K | $184K | -$2.70M |
| **Investing Cash Flow** | -$20K | -$39K | -$41K | -$11K | -$44K | -$3.2K | -$24K | -$37K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -$4.20M |
| **Financing Cash Flow** | $345K | $610K | $148K | $67K | $8.23M | $245K | -$509K | $2.54M |
| **Net Change in Cash** | -$756K | -$758K | -$3.01M | -$1.47M | $6.72M | $186K | -$326K | -$160K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2016 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 56.5% | 31.3% | 23.4% | -41.4% | -54.9% | -- | -- | -- | -- | -- |
| **Operating Margin** | -46.5% | -344.3% | -612.3% | -5860.2% | -5735.9% | -- | -- | -- | -- | -4646.1% |
| **Net Profit Margin** | -39.6% | -356.7% | -607.4% | -5842.0% | -5584.3% | -- | -- | -- | -- | -4688.7% |
| Return on Equity (ROE) | -51.0% | -1498.5% | -189.8% | -104.1% | -151.8% | -660.2% | -- | -- | -- | -- |
| Return on Assets (ROA) | -33.4% | -229.4% | -146.5% | -78.0% | -125.3% | -286.6% | -1273.2% | -6.3% | -3420.2% | -17680.0% |
| Current Ratio | 4.44x | 2.09x | 4.08x | 3.93x | 6.17x | 1.76x | 0.17x | 0.85x | 0.02x | 0.01x |
| Quick Ratio | 3.47x | 0.90x | 3.12x | 3.70x | 6.09x | 1.71x | 0.15x | 0.77x | 0.00x | 0.01x |
| Debt to Equity | 0.04x | 0.32x | 0.06x | 0.02x | 0.06x | 0.73x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +163.5% | +76.9% | +1040.7% | -3.9% | -- | -- | -- | -- | -100.0% | -38.1% |
| Gross Profit Growth (YoY) | +376.2% | +136.5% | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -- | -- | -- | -100.0% | -100.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 55.7% | 54.5% | 54.9% | 56.5% | 56.6% | 54.2% | 47.7% | 31.3% |
| **Operating Margin** | -76.1% | -72.7% | -87.7% | -46.5% | -85.6% | -114.3% | -118.0% | -344.3% |
| **Net Profit Margin** | -74.5% | -71.4% | -78.3% | -39.6% | -80.5% | -114.7% | -125.0% | -356.7% |
| Return on Equity (ROE) | -197.6% | -136.7% | -106.7% | -51.0% | -65.3% | -586.5% | -244.9% | -1498.5% |
| Return on Assets (ROA) | -120.4% | -88.2% | -79.6% | -33.4% | -49.3% | -148.2% | -110.7% | -229.4% |
| Current Ratio | 2.84x | 4.38x | 6.41x | 4.44x | 7.13x | 2.13x | 3.64x | 2.09x |
| Quick Ratio | 1.71x | 3.28x | 5.09x | 3.47x | 5.80x | 1.09x | 2.41x | 0.90x |
| Debt to Equity | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x | 0.28x | 0.12x | 0.32x |
| **Revenue Growth (YoY)** | +16.3% | +72.5% | -11.7% | +906.6% | +105.4% | +0.7% | +234.9% | -63.3% |
| Gross Profit Growth (YoY) | +29.3% | +66.9% | -18.6% | +983.7% | +224.6% | +97.5% | +623.5% | -27.2% |
| Operating Income Growth (YoY) | -- | -- | -199.8% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -180.5% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -150.0% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -1597.6% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -1819.0% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
